XML 82 R71.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION AND BENEFIT PLAN - Equity Plans (Details) - shares
Mar. 31, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding (in shares) 19,102,010 16,684,325
Inducement Award Program    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding (in shares) 211,088  
Keryx Equity Plans    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Awards outstanding (in shares) 153,346 163,765
Additional awards authorized for grant (in shares) 0 0
Akebia Therapeutics, Inc. 2014 Incentive Plan, as amended (the 2014 Plan) (replaces 2008 Plan)    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Awards outstanding (in shares) 10,314,595 11,559,708
Additional awards authorized for grant (in shares) 0 0
Akebia Therapeutics, Inc. 2014 Incentive Plan, as amended (the 2014 Plan) (replaces 2008 Plan) | Inducement Award Program    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding (in shares) 1,120,196 1,151,127
Akebia Therapeutics, Inc. 2023 Stock Incentive Plan (the 2023 Plan) (replaces 2014 Plan)    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Awards outstanding (in shares) 16,092,744 10,390,642
Additional awards authorized for grant (in shares) 4,399,444 11,340,648
Akebia Therapeutics, Inc. 2023 Stock Incentive Plan (the 2023 Plan) (replaces 2014 Plan) | Inducement Award Program    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding (in shares) 2,274,138 2,534,775